½ÃÀ庸°í¼­
»óǰÄÚµå
1824202

¸¶Ãë ¹× È£Èí±â ½ÃÀå : ¿¹Ãø(2025-2030³â)

Anesthesia and Respiratory Devices Market - Forecasts from 2025 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Knowledge Sourcing Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 151 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¸¶Ã롤ȣÈí±â ½ÃÀå ±Ô¸ð :

¸¶Ã롤ȣÈí±â ½ÃÀåÀº CAGR 5.92%·Î, 2025³â 535¾ï 1,400¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 713¾ï 4,400¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸¶Ãë ¹× È£Èí±â´Â ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ ÀÖÀ¸¸ç, ¼­·Î ´Ù¸£Áö¸¸ Á¾Á¾ »óÈ£ º¸¿ÏÀûÀÎ ±â´ÉÀ» ¼öÇàÇÏ´Â Áß¿äÇÑ ÀÇ·á±â±â¸¦ ³ªÅ¸³À´Ï´Ù. ¸¶Ãë ÀåÄ¡´Â ÀÇ·á ½Ã¼úÀ» ¹Þ´Â ȯÀÚ¿¡°Ô ÅëÁ¦µÈ ¸¶Ãë Åõ¿©¸¦ Á¦°øÇϰí, ¿Ü°úÀû, ³»°úÀû, Á¤½Å°úÀû °³ÀÔÀ» ¿øÈ°ÇÏ°Ô ¼öÇàÇϱâ À§ÇØ ÅëÁõ°ú °¨°¢À» ¿ÏÈ­ÇÏ´Â ¾ÈÁ¤µÈ ¸¶Ãë È帧À» À¯ÁöÇÕ´Ï´Ù. È£Èí±â Àåºñ´Â ½Ã¼ú Áß ½Åü¿¡ ÃæºÐÇÑ »ê¼Ò È帧À» º¸ÀåÇϰí õ½Ä, ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), Æó¾Ï°ú °°Àº ÁßÁõ ¸¸¼º ÆóÁúȯ ¹× ÀÚ¿¬Àû »ê¼Ò »ý¼º ´É·ÂÀÌ ÀúÇÏµÈ È¯ÀÚ¿¡°Ô ÇʼöÀûÀÎ Áö¿øÀ» Á¦°øÇÕ´Ï´Ù.

¸¶Ãë¿Í È£Èí±âÀÇ Á¶ÇÕÀ¸·Î ¼ö¼ú Áß Á¾ÇÕÀûÀΠȯÀÚ °ü¸®°¡ °¡´ÉÇϸç, È£Èí±â ÇÕº´ÁõÀ» ¿¹¹æÇÏ°í °¨°¢À» °¨¼Ò½ÃŰ¸é¼­ ¼ö¼ú Áß È¯ÀÚ °ü¸®¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅëÇÕÀû Á¢±Ù ¹æ½ÄÀº ´Ù¾çÇÑ ÀÇ·á ¿ëµµ¿¡¼­ ȯÀÚÀÇ ¾ÈÀü°ú ½Ã¼úÀÇ È¿°ú¸¦ º¸ÀåÇÕ´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

¸¸¼ºÁúȯ À¯º´·ü Áõ°¡

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ Áß Ã¹ ¹øÂ°´Â Àü ¼¼°è¿¡¼­ ¸¸¼ºÁúȯ Áõ°¡·Î ¸¶Ãë ¹× È£Èí±â¿¡ ´ëÇÑ °­·ÂÇÑ ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ Áúº´ÅëÁ¦¿¹¹æ¼¾ÅÍ ÀÚ·á¿¡ µû¸£¸é ¹Ì±¹ ¼ºÀÎ 10¸í Áß 6¸íÀÌ ¸¸¼ºÁúȯÀ» ¾Î°í ÀÖÀ¸¸ç, 10¸í Áß 4¸íÀº ¿©·¯ °³ÀÇ ¸¸¼ºÁúȯÀ» ¾Î°í ÀÖ½À´Ï´Ù. È£ÁÖ º¸°Ç Åë°è¿¡ µû¸£¸é ¼ºÀÎ 5¸í Áß 1¸íÀº ¿©·¯ °¡Áö ¸¸¼ºÁúȯÀ» ¾Î°í ÀÖÀ¸¸ç, ÀÔ¿ø ȯÀÚ 2¸í Áß 1¸íÀº ¸¸¼ºÁúȯÀÇ ÁßÁõµµ¿Í °ü·ÃÀÌ ÀÖ½À´Ï´Ù.

¼¼°èº¸°Ç±â±¸(WHO)´Â ½ÉÇ÷°ü°è ÁúȯÀÌ Àü ¼¼°è ¿¬°£ »ç¸ÁÀÚÀÇ 30% ÀÌ»óÀ» Â÷ÁöÇÏ´Â ÁÖ¿ä »ç¸Á¿øÀÎÀ̶ó°í ¹àÇû½À´Ï´Ù. ´ë±â¿À¿° Áõ°¡´Â ÆóÁúȯ°ú Æó¾Ï Áõ°¡·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ °¡È¤ÇÑ ³ëµ¿ ½ºÄÉÁÙ°ú º¹ÀâÇÑ »ýȰ ½À°üÀº ÀÇ·áÀû °³ÀÔÀÌ ÇÊ¿äÇÑ CVD¿Í À§ÀåÁúȯ Áõ°¡¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ¿¹¹æ°ú »ý¸íÀ» »ì¸®±â À§ÇÑ ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÀÇ·á ¼ö¿ä Áõ°¡¸¦ ÅëÇØ ¸¶Ãë ¹× È£Èí±â ½ÃÀå ±Ô¸ð°¡ Å©°Ô È®´ëµÇ°í ÀÖ½À´Ï´Ù.

ÀÇ·á ÀÎÇÁ¶ó °³¹ß

ÀÇ·á ÀÎÇÁ¶ó °³¹ß ¹× ÁöÃâ Áõ°¡´Â º´¿ø ¹× ÀÇ·á½Ã¼³ÀÇ °Ç¼³À» °¡¼ÓÈ­ÇÏ¿© Àåºñ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÎÇÁ¶óÀÇ È®ÀåÀº ½Ã¼³ÀÇ ¿î¿µ ´É·ÂÀ» Áö¿øÇϱâ À§ÇØ Á¾ÇÕÀûÀÎ ¸¶Ãë ¹× È£Èí±â ÀåºñÀÇ ¼³Ä¡°¡ ÇÊ¿äÇϹǷΠÁö¼ÓÀûÀÎ ½ÃÀå ¼ºÀå ±âȸ¸¦ âÃâÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àα¸ °í·ÉÈ­

°í·ÉÈ­ Àα¸ Áõ°¡¿Í ±×¿¡ µû¸¥ ³ëÈ­¿Í °ü·ÃµÈ °Ç°­»óÀÇ ÇÕº´ÁõÀº Æó Áúȯ ¹× ±âŸ ³ëÈ­ °ü·Ã Áúȯ¿¡ ´ëóÇϱâ À§ÇÑ È£Èí±â Àåºñ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àα¸ Ãß¼¼´Â ÀÇ·á ½Ã½ºÅÛÀÌ Àü¹®ÀûÀΠȣÈí±â Áö¿øÀ» ÇÊ¿ä·Î ÇÏ´Â °í·ÉÈ­ Àα¸¿¡ ´ëÀÀÇϱâ À§ÇØ ÀÇ·á ½Ã½ºÅÛÀÌ ÀûÀÀÇÔ¿¡ µû¶ó Àå±âÀûÀÎ ½ÃÀå È®´ë Àü¸ÁÀ» ³º°í ÀÖ½À´Ï´Ù.

±â¼ú Çõ½Å

¾÷°è³» ±â¼ú ¹ßÀüÀº ±â±â ±â´É °­È­, ȯÀÚ °á°ú °³¼±, ÀÀ¿ë °¡´É¼º È®´ë¸¦ ÅëÇØ ½ÃÀå ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀº Àüü ÀÇ·á½Ã¼³ÀÇ ±³Ã¼ ÁÖ±â¿Í ÷´Ü ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀ» ÃËÁøÇÕ´Ï´Ù.

Áö¿ªº° ½ÃÀå ºÐ¼®

¾Æ½Ã¾ÆÅÂÆò¾ç ¼ºÀå Àü¸Á

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¸¶Ãë ¹× È£Èí±â ½ÃÀåÀº ¿¹Ãø ±â°£ Áß °ß°íÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Ãֽбâ¼úÀ» µµÀÔÇÒ ¼ö ÀÖ´Â ÀÎÇÁ¶ó °³¹ß Áõ°¡¿Í Àú·ÅÇÑ °¡°ÝÀÇ ¾çÁúÀÇ ÀÇ·á ¼­ºñ½º°¡ ÀÌ Áö¿ªÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ª¿¡¼­´Â ƯÈ÷ ű¹, ¸»·¹À̽þÆ, Àεµ, ½Ì°¡Æ÷¸£, Çѱ¹ µî¿¡¼­ ÀÇ·á°ü±¤ Ȱµ¿ÀÌ È°¹ßÈ÷ ÀÌ·ç¾îÁö°í ÀÖÀ¸¸ç, Àú·ÅÇÑ ÀÇ·á¼­ºñ½º°¡ ÁÖ¿ä ¸Å·ÂÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÇ·áºñ ¿ìÀ§´Â ¿Ü±¹ÀΠȯÀڵ鿡°Ô »ó´çÇÑ ºñ¿ë Àý°¨À» °¡Á®´Ù ÁÖ¸ç, ÀÇ·á ½Ã¼ú ¹× ¼ö¼úÀº ´Ù¸¥ ½ÅÈï ½ÃÀå°ú ºñ±³ÇÏ¿© ºñ¿ë Àý°¨ È¿°ú°¡ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºñ¿ë °æÀï·ÂÀ¸·Î ¾Æ½Ã¾ÆÅÂÆò¾çÀº Áö¼ÓÀûÀÎ ½ÃÀå È®´ë¸¦ ±â´ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÇ·á°ü±¤°´ À¯Ä¡¸¦ À§ÇÑ Á¤ºÎÀÇ ¿ìÈ£ÀûÀÎ Á¤Ã¥Àº ¿¹Ãø ±â°£ Áß ½ÃÀå ±Ô¸ð¸¦ È®´ëÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±¹³»¿Ü ȯÀÚ¸¦ À§ÇÑ ÀÎÇÁ¶ó °³¼±À» À§ÇÑ Á¤ºÎ ÀÇ·áºñ ÁöÃâ Áõ°¡´Â ÀÇ·á°ü±¤°ú ¸¶Ãë ¹× È£Èí±â ½ÃÀåÀÇ µ¿½Ã ¼ºÀåÀ» Áö¿øÇÕ´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÁÖ¿ä ÀåÁ¡

  • ÀλçÀÌÆ® ºÐ¼® : °í°´ ºÎ¹®, Á¤ºÎ Á¤Ã¥ ¹× »çȸ°æÁ¦Àû ¿äÀÎ, ¼ÒºñÀÚ ¼±È£µµ, »ê¾÷º°, ±âŸ ÇÏÀ§ ºÎ¹®¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÁÖ¿ä Áö¿ª»Ó¸¸ ¾Æ´Ï¶ó ½ÅÈï Áö¿ª±îÁö Æ÷°ýÇÏ´Â »ó¼¼ÇÑ ½ÃÀå ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.
  • °æÀï ±¸µµ: ¼¼°è ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇϰí ÀÖ´Â Àü·«Àû Àü·«À» ÀÌÇØÇϰí, ÀûÀýÇÑ Àü·«À» ÅëÇÑ ½ÃÀå ħÅõ °¡´É¼ºÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀΰú ¹Ì·¡ µ¿Çâ : ¿ªµ¿ÀûÀÎ ¿äÀΰú ¸Å¿ì Áß¿äÇÑ ½ÃÀå µ¿Çâ, ±×¸®°í À̵éÀÌ ÇâÈÄ ½ÃÀå ¹ßÀüÀ» ¾î¶»°Ô Çü¼ºÇÒ °ÍÀÎÁö¿¡ ´ëÇØ ¾Ë¾Æº¾´Ï´Ù.
  • ½ÇÇà °¡´ÉÇÑ Á¦¾È: ¿ªµ¿ÀûÀΠȯ°æ ¼Ó¿¡¼­ »õ·Î¿î ºñÁî´Ï½º ½ºÆ®¸²°ú ¸ÅÃâÀ» ¹ß±¼Çϱâ À§ÇÑ Àü·«Àû ÀÇ»ç°áÁ¤¿¡ ÀλçÀÌÆ®¸¦ Ȱ¿ëÇÕ´Ï´Ù.
  • ´Ù¾çÇÑ »ç¿ëÀÚ¿¡ ´ëÀÀ: ½ºÅ¸Æ®¾÷, ¿¬±¸±â°ü, ÄÁ¼³ÅÏÆ®, Áß¼Ò±â¾÷, ´ë±â¾÷¿¡ À¯ÀÍÇÏ°í ºñ¿ë È¿À²ÀûÀÔ´Ï´Ù.

¾î¶² ¿ëµµ·Î »ç¿ëµÇ´Â°¡?

»ê¾÷ ¹× ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç° ¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÃâ Àü·«, Áö¿ªÀû È®Àå, ¼³ºñ ÅõÀÚ °áÁ¤, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿Í ¿µÇâ, ½ÅÁ¦Ç° °³¹ß, °æÀïÀÇ ¿µÇâ

ºÐ¼® ¹üÀ§

  • °ú°Å µ¥ÀÌÅÍ(2022-2024³â) ¹× ¿¹Ãø µ¥ÀÌÅÍ(2025-2030³â)
  • ¼ºÀå ±âȸ, °úÁ¦, °ø±Þ¸Á Àü¸Á, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, °í°´ Çൿ, µ¿Ç⠺м®
  • °æÀï»ç Æ÷Áö¼Å´×, Àü·« ¹× ½ÃÀå Á¡À¯À² ºÐ¼®
  • ¸ÅÃâ ¼ºÀå·ü ¹× ¿¹Ãø ºÐ¼® : ºÎ¹®º°/Áö¿ªº°(±¹°¡º°)
  • ±â¾÷ ÇÁ·ÎÆÄÀϸµ(Àü·«, Á¦Ç°, À繫Á¤º¸, ÁÖ¿ä µ¿Çâ µî)

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀå ½º³À¼ô

  • ½ÃÀå °³¿ä
  • ½ÃÀåÀÇ Á¤ÀÇ
  • ºÐ¼® ¹üÀ§
  • ½ÃÀå ¼¼ºÐÈ­

Á¦3Àå ºñÁî´Ï½º »óȲ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • Porter's Five Forces ºÐ¼®
  • ¾÷°èÀÇ ¹ë·ùüÀÎ ºÐ¼®
  • Á¤Ã¥°ú ±ÔÁ¦
  • Àü·«Àû Á¦¾È

Á¦4Àå ±â¼ú Àü¸Á

Á¦5Àå ¸¶Ã롤ȣÈí±â ½ÃÀå : Á¦Ç°º°

  • ¼­·Ð
  • ¸¶Ãë±â
  • ¸¶Ãë¿ë ÀÏȸ¿ë Á¦Ç°
  • È£Èí±â Àåºñ
  • ÀÏȸ¿ë È£Èí±â ±â±â
  • È£Èí ÃøÁ¤ ±â±â

Á¦6Àå ¸¶Ã롤ȣÈí±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼­·Ð
  • º´¿ø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ(ASC)
  • ÀçÅà ÀÇ·á
  • Ŭ¸®´Ð¡¤Áø´Ü ¼¾ÅÍ

Á¦7Àå ¸¶Ã롤ȣÈí±â ½ÃÀå : Áö¿ªº°

  • ¼­·Ð
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • ³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ½ºÆäÀÎ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • Àεµ³×½Ã¾Æ
    • ű¹
    • ±âŸ

Á¦8Àå °æÀï ȯ°æ°ú ºÐ¼®

  • ÁÖ¿ä ±â¾÷°ú Àü·« ºÐ¼®
  • ½ÃÀå Á¡À¯À² ºÐ¼®
  • ±â¾÷ÀμöÇÕº´(M&A), ÇÕÀÇ, Çù¾÷
  • °æÀï ´ë½Ãº¸µå

Á¦9Àå ±â¾÷ °³¿ä

  • Smiths Medical
  • General Electric
  • Teleflex Incorporated
  • Getinge AB
  • OSI Systems Inc
  • Koninklijke Philips N.V.
  • Invacare Corporation
  • ResMed
  • Masimo
  • Fisher & Paykel Healthcare Limited
  • Medtronic

Á¦10Àå ºÎ·Ï

  • ÅëÈ­
  • ÀüÁ¦Á¶°Ç
  • ±âÁØ¿¬µµ¿Í ¿¹Ãø¿¬µµ ŸÀÓ¶óÀÎ
  • ÀÌÇØ°ü°èÀÚ¿¡ ´ëÇÑ ÁÖ¿ä ÀÌÁ¡
  • ºÐ¼® ¹æ¹ý
  • ¾à¾î

µµÇ¥ ¸®½ºÆ®

Ç¥ ¸®½ºÆ®

KSA

Anesthesia and Respiratory Devices Market Size:

The anesthesia and respiratory devices market is expected to grow from USD 53.514 billion in 2025 to USD 71.344 billion in 2030, at a CAGR of 5.92%.

Anesthesia and respiratory devices represent critical medical equipment serving distinct but often complementary functions in healthcare delivery. Anesthesia devices deliver controlled anesthesia administration to patients undergoing medical procedures, maintaining steady anesthetic flow to reduce pain and sensation for smoother procedural execution across surgical, medical, and psychiatric interventions. Respiratory devices ensure adequate oxygen flow to the body during procedures and provide essential support for patients with severe chronic lung diseases including asthma, chronic obstructive pulmonary disease (COPD), lung cancer, and other conditions compromising natural oxygen generation capacity.

The combination of anesthesia and respiratory devices enables comprehensive patient care during surgical procedures, reducing sensation while preventing respiratory complications. This integrated approach ensures patient safety and procedural efficacy across diverse medical applications.

Market Growth Drivers

Rising Chronic Disease Prevalence

The primary market driver is the escalating incidence of chronic diseases worldwide, creating robust demand for anesthesia and respiratory devices. Chronic disease prevalence has reached significant levels globally, with data from the Center for Disease Control and Prevention indicating that 6 out of 10 adults in America suffer from chronic disease, while 4 out of 10 have multiple chronic conditions. Australian health statistics reveal that 1 in 5 adults suffers from multiple chronic diseases, with 1 in every 2 hospitalizations linked to chronic disease severity.

Cardiovascular disease represents the most common chronic condition globally, with the World Health Organization identifying CVDs as the leading cause of death worldwide, accounting for more than 30% of annual global deaths. Rising air pollution levels have contributed to increased lung disease and lung cancer cases. Additionally, demanding work schedules combined with complex lifestyle factors have significantly contributed to rising CVD and gastric disease incidences requiring medical intervention.

The growing prevalence of chronic diseases necessitates increased medical attention for prevention and life-saving procedures, substantially expanding the anesthesia and respiratory devices market size through heightened healthcare demand.

Healthcare Infrastructure Development

Rising healthcare infrastructure development and expenditure have accelerated hospital and healthcare unit construction, driving equipment demand. This infrastructure expansion creates sustained market growth opportunities as facilities require comprehensive anesthesia and respiratory device installations to support their operational capacity.

Aging Population Demographics

The growing aging population and associated age-related health complexities drive respiratory device demand to address lung diseases and other age-related conditions. This demographic trend creates long-term market expansion prospects as healthcare systems adapt to serve aging populations requiring specialized respiratory support.

Technological Innovation

Technological advancement within the industry contributes significantly to market growth through enhanced device capabilities, improved patient outcomes, and expanded application possibilities. Innovation drives replacement cycles and adoption of advanced solutions across healthcare facilities.

Regional Market Analysis

Asia Pacific Growth Prospects

The Asia Pacific anesthesia and respiratory device market demonstrates robust growth projections during the forecast period. Rising infrastructure development enabling modern technology adoption, coupled with affordable, quality healthcare services, drives regional segment growth. The region has experienced increased medical tourism activity, particularly in Thailand, Malaysia, India, Singapore, and South Korea, where affordable medical services represent primary attractions.

Healthcare cost advantages in the Asia Pacific region provide substantial savings for international patients, with medical procedures and surgeries offering cost reductions compared to other developed markets. This cost competitiveness positions the region for continued market expansion.

Favorable government policies designed to attract medical tourists are anticipated to increase market scope during the forecast period. Rising government healthcare expenditure to improve infrastructure for both domestic and international patients supports concurrent growth in medical tourism and anesthesia and respiratory device markets.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Anesthesia and Respiratory Devices Market Segments:

By Products

  • Anaesthesia Machines
  • Anesthesia Disposables
  • Respiratory Equipment
  • Respiratory Disposable Devices
  • Respiratory Measurement Devices

By End-User

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Homecare Settings
  • Clinics and Diagnostics Centers

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ANESTHESIA AND RESPIRATORY DEVICES MARKET BY PRODUCTS

  • 5.1. Introduction
  • 5.2. Anaesthesia Machines
  • 5.3. Anesthesia Disposables
  • 5.4. Respiratory Equipment
  • 5.5. Respiratory Disposable Devices
  • 5.6. Respiratory Measurement Devices

6. ANESTHESIA AND RESPIRATORY DEVICES MARKET BY END-USER

  • 6.1. Introduction
  • 6.2. Hospitals
  • 6.3. Ambulatory Surgical Centers (ASCs)
  • 6.4. Homecare Settings
  • 6.5. Clinics and Diagnostics Centers

7. ANESTHESIA AND RESPIRATORY DEVICES MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. USA
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. United Kingdom
    • 7.4.4. Spain
    • 7.4.5. Others
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. UAE
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. India
    • 7.6.3. Japan
    • 7.6.4. South Korea
    • 7.6.5. Indonesia
    • 7.6.6. Thailand
    • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Smiths Medical
  • 9.2. General Electric
  • 9.3. Teleflex Incorporated
  • 9.4. Getinge AB
  • 9.5. OSI Systems Inc
  • 9.6. Koninklijke Philips N.V.
  • 9.7. Invacare Corporation
  • 9.8. ResMed
  • 9.9. Masimo
  • 9.10. Fisher & Paykel Healthcare Limited
  • 9.11. Medtronic

10. APPENDIX

  • 10.1. Currency
  • 10.2. Assumptions
  • 10.3. Base and Forecast Years Timeline
  • 10.4. Key benefits for the stakeholders
  • 10.5. Research Methodology
  • 10.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦